Enzo Biochem, Inc. ($0.01 Par Value) (ENZ): Price and Financial Metrics


Enzo Biochem, Inc. ($0.01 Par Value) (ENZ)

Today's Latest Price: $1.82 USD

0.14 (-7.14%)

Updated Oct 30 7:00pm

Add ENZ to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

ENZ Stock Summary

  • With a one year PEG ratio of 0.14, Enzo Biochem Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than just 3.57% of US stocks.
  • With a year-over-year growth in debt of 685.38%, Enzo Biochem Inc's debt growth rate surpasses 97.11% of about US stocks.
  • Over the past twelve months, ENZ has reported earnings growth of -2,121.91%, putting it ahead of just 0.86% of US stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Enzo Biochem Inc are MYGN, JMP, CALM, OFIX, and UFCS.
  • Visit ENZ's SEC page to see the company's official filings. To visit the company's web site, go to www.enzo.com.

ENZ Stock Price Chart Interactive Chart >

Price chart for ENZ

ENZ Price/Volume Stats

Current price $1.82 52-week high $4.85
Prev. close $1.96 52-week low $1.56
Day low $1.80 Volume 319,851
Day high $1.96 Avg. volume 750,953
50-day MA $2.17 Dividend yield N/A
200-day MA $2.42 Market Cap 87.17M

Enzo Biochem, Inc. ($0.01 Par Value) (ENZ) Company Bio


Enzo Biochem, Inc. engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company was founded in 1976 and is based in New York, New York.


ENZ Latest News Stream


Event/Time News Detail
Loading, please wait...

ENZ Latest Social Stream


Loading social stream, please wait...

View Full ENZ Social Stream

Latest ENZ News From Around the Web

Below are the latest news stories about Enzo Biochem Inc that investors may wish to consider to help them evaluate ENZ as an investment opportunity.

Edited Transcript of ENZ earnings conference call or presentation 8-Jun-20 9:00pm GMT

Q3 2020 Enzo Biochem Inc Earnings Call

Yahoo | August 3, 2020

Enzo Biochem to provide COVID-19 testing at 50+ New York pharmacies

Enzo Biochem ([[ENZ]] -0.6%) partners with Community Pharmacy Enhanced Services Network, to provide COVID-19 testing at 52 of the network’s 155 pharmacies across New York State.The company will provide the full range of services, including reagent manufacturing capabilities, diagnostic instruments, and clinical laboratory services....

Seeking Alpha | July 21, 2020

ENZO BIOCHEM TO PROVIDE ACCESS TO COVID-19 TESTING AT MORE THAN 50 NY PHARMACIES IN COLLABORATION WITH CPESN NY

NEW YORK, NY, July 21, 2020 -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostic company, and Community Pharmacy Enhanced Services Network (CPESN® NY), the.

Yahoo | July 21, 2020

Do Insiders Own Lots Of Shares In Enzo Biochem, Inc. (NYSE:ENZ)?

The big shareholder groups in Enzo Biochem, Inc. (NYSE:ENZ) have power over the company. Institutions will often hold...

Yahoo | July 17, 2020

Enzo Biochem shares rise on FDA authorization for coronavirus test

Shares of Enzo Biochem Inc. rallied 7.7% in premarket trading on Monday after the company said it received an emergency use authorization from the Food and Drug Administration for its COVID-19 diagnostic test. The regulator issued the EUA on July 7. It has granted emergency authorization to at least 137 diagnostic tests during the COVID-19 pandemic. Enzo's stock is up 8.7% year-to-date. The S&P 500 has declined 1.4% since the start of the year.

Yahoo | July 13, 2020

Read More 'ENZ' Stories Here

ENZ Price Returns

1-mo -15.35%
3-mo -23.53%
6-mo -38.31%
1-year -43.13%
3-year -80.82%
5-year -52.36%
YTD -30.80%
2019 -5.40%
2018 -65.89%
2017 17.44%
2016 54.22%
2015 1.35%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7059 seconds.